Kirin (OTCMKTS:KNBWY) Shares Gap Up – Still a Buy?

Kirin Holdings Co. (OTCMKTS:KNBWY) gapped up before the market opened on Monday. The stock had previously closed at $17.82, but opened at $18.41. Kirin shares last traded at $18.1450, with a volume of 2,309 shares.

Analyst Upgrades and Downgrades

Separately, Zacks Research downgraded Kirin from a “hold” rating to a “strong sell” rating in a research note on Monday, August 31st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Kirin currently has an average rating of “Sell”.

Kirin Trading Down 1.8%

The firm has a market capitalization of $14.63 billion, a PE ratio of 11.50 and a beta of -0.01. The company has a quick ratio of 1.02, a current ratio of 1.48 and a debt-to-equity ratio of 0.48. The stock’s fifty day simple moving average is $18.63 and its 200 day simple moving average is $17.35.

Kirin (OTCMKTS:KNBWY) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.16. Kirin had a return on equity of 12.22% and a net margin of 7.79%.The business had revenue of $4.08 billion during the quarter, compared to analysts’ expectations of $3.87 billion. On average, sell-side analysts predict that Kirin Holdings Co. will post 1.34 earnings per share for the current year.

About Kirin

Kirin Holdings Company, Limited is a Japan-based company with businesses spanning alcoholic and nonalcoholic beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks, bottled water and other consumer products marketed under brands such as Kirin, Ichiban Shibori and Afternoon Tea.

The company’s pharmaceutical business is conducted primarily through Kyowa Kirin, which researches, develops and commercializes prescription medicines, including treatments in areas such as oncology, immunology and nephrology.